Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.45%
#2 Venom Venom +23.49%
#3 Decred Decred +10.61%
#4 Wibx Wibx +8.05%
#5 Status Status +7.45%
#6 SkyAI SkyAI +7.31%
#7 aelf aelf +6.44%
#8 MarsCoin MarsCoin +5.78%
#9 Audiera Audiera +5.39%
#10 TRIA TRIA +4.71%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Finch Therapeutics Group, Inc. Finch Therapeutics Group, Inc.

Finch Therapeutics Group, Inc.

FNCH
Rangering i aksjer #30545
Finch Therapeutics is a microbiome technology company with a portfolio of... Finch Therapeutics is a microbiome technology company with a portfolio of intellectual property and microbiome assets. The company is now focused on realizing the value of its intellectual property estate and other assets, while supporting the advancement of its microbiome technology through partnerships and collaborations after winding down development efforts.
Aksjekurs
$10.20
Sist synkronisert: 2026-08-05
Markedsverdi
$16.38M
Endring (1 dag)
2.00%
Endring (1 år)
-18.40%
Land
US
Handel Finch Therapeutics Group, Inc. (FNCH)

Kategori

Healthcare
Aksjeprishistorikk for Finch Therapeutics Group, Inc. (FNCH)
Høyeste sluttskurs: $10.20 den 2026-08-01

Laveste sluttskurs: $509.37 den 2021-03-01
Aksjeprishistorikk for Finch Therapeutics Group, Inc. fra 2021 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -13.21%
2025 19.77%
2024 211.15%
2023 -82.69%
2022 -93.58%
2021 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.89 35.09%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $996.61 51.72%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $114.93 -21.05%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $735.86 6.07%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $257.75 14.92%
BE